US2004167610A1PendingUtilityA1
Locking stent
Priority: Feb 26, 2003Filed: Feb 26, 2003Published: Aug 26, 2004
Est. expiryFeb 26, 2023(expired)· nominal 20-yr term from priority
Inventors:James A. Fleming, Iii
A61F 2/915A61F 2/91A61F 2002/91583A61F 2002/91533A61F 2002/91591A61F 2230/0054A61M 29/02
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A locking stent has a lattice of interconnecting elements defining a substantially cylindrical configuration having a first open end and a second open end. The lattice has a closed configuration and an open configuration. The lattice also has a plurality of adjacent hoops wherein each hoop is separated from another hoop in the closed configuration. Each hoop mateably connects with or interlocks with an adjacent hoop in the open configuration.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A stent comprising:
a lattice of interconnecting elements defining a substantially cylindrical configuration having a first open end and a second open end, the lattice having a closed configuration and an open configuration; the lattice comprising a plurality of adjacent hoops, each hoop separated from another hoop in the closed configuration and each hoop interlocking with another hoop in the open configuration.
2 . The stent according to claim 1 , wherein each hoop comprises a plurality of loops.
3 . The stent according to claim 2 , wherein each hoop further comprises a plurality of struts connected to the loops.
4 . The stent according to claim 3 , wherein at least one loop of one hoop comprises a male end and at least one loop of another hoop comprises a female end, wherein the male end is separated from the female end when the lattice is in the closed configuration and wherein the male end is mateably connected to the female end when the lattice is in the open configuration.
5 . The stent according to claim 4 , wherein the male end of at least one loop of one hoop and the female end of at least one loop of another hoop form a locked joint when the lattice is in the open configuration.
6 . The stent according to claim 5 , wherein the lattice further comprises at least one flexible link connected between adjacent hoops.
7 . The stent according to claim 6 , wherein the at least one flexible link is connected between the loops of adjacent hoops.
8 . The stent according to claim 4 , wherein the plurality of struts and the loops define at least one pre-configured cell.
9 . The stent according to claim 7 , wherein the plurality of struts and the loops define at least one pre-configured cell.
10 . The stent according to claim 9 , wherein the plurality of struts and the loops define at least one partial cell.
11 . The stent according to claim 10 , wherein the partial cell is defined when the lattice is in the closed configuration.
12 . The stent according to claim 7 , wherein the plurality of struts and the loops define at least one formed cell.
13 . The stent according to claim 12 , wherein the at least one formed cell is defined when the lattice is in the open configuration.
14 . The stent according to claim 4 , wherein the male end has a substantially convex configuration.
15 . The stent according to claim 14 , wherein the female end has a substantially concave configuration.
16 . The stent according to claim 9 , wherein the at least one pre-configured cell has a substantially diamond shape.
17 . The stent according to claim 4 , wherein the lattice further comprises a drug coating.
18 . The stent according to claim 4 , wherein the lattice further comprises a drug and polymer coating combination.
19 . The stent according to claim 17 , wherein the drug is rapamycin.
20 . The stent according to claim 18 , wherein the drug is rapamycin.
21 . The stent according to claim 17 , wherein the drug is paclitaxel.
22 . The stent according to claim 18 , wherein the drug is paclitaxel.
23 . The stent according to claim 4 , wherein the stent is made of an alloy.
24 . The stent according to claim 23 , wherein the stent is made of stainless steel.
25 . The stent according to claim 4 , wherein the stent is crush recoverable.
26 . The stent according to claim 25 wherein the stent is made of nickel titanium (NiTi).
27 . The stent according to claim 23 , wherein the stent is made of a super elastic alloy.
28 . The stent according to claim 27 , wherein the stent is made of nickel titanium (NiTi).Join the waitlist — get patent alerts
Track US2004167610A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.